Press Release 20 Jul 2010

Over 200 customer service positions centralised in Dublin from across Europe; R&D investment to be announced for Ireland later this year

Dublin, Ireland – July 20, 2010 – Covidien, a leading global supplier of healthcare products, today announced the official opening of its Cherrywood European Services Centre and the creation of more than 200 jobs since 2009. €11 million has been invested in the state of the art Cherrywood contact centre which houses customer services, credit control, contracts & pricing and import & export functions for 16 European countries.  The Cherrywood site is also the base for Covidien’s sales and marketing teams in Ireland. 

Covidien also announced today that it will be putting an initial €1.8 million investment into a medical technologies research and development project which will involve three Irish academic institutions.  Full details of the project will be announced later in the year.

The opening of the centre was performed today by the Taoiseach/Prime Minister of Ireland Mr. Brian Cowen who was accompanied by the Minister for Enterprise, Trade and Innovation Mr. Batt O’Keeffe, and Richard J. Meelia, Chairman, President and CEO of Covidien.

At the opening today, the Taoiseach said, “This new European Services Centre and today’s announcement of new investment in collaborative research and development is very much in keeping with the Government’s policy to build a Smart Economy and to position Ireland as a global innovation hub.

In his remarks, Mr. Meelia highlighted the benefits of centralising the European functions into Ireland. “Covidien has manufactured in Ireland for more than 30 years,” he said. “Ireland is, in fact, where we have the greatest number of employees in all of Europe. Our excellent experience here, coupled with the Government’s long-standing policies supporting business and innovation, clearly makes Ireland an ideal base for our Company.”

The Minister for Enterprise, Trade and Innovation, Batt O'Keeffe TD, said, “Covidien is one of the leading medical device firms based in Ireland. The new European Services Centre reaffirms Covidien's commitment to Ireland and demonstrates to the global investor community that we have the right mix of skills, workforce flexibility and pro-business policies to support business expansion plans and create jobs. I look forward to Covidien's planned medical technologies research and development investment which will recognize our reputation as Europe's emerging innovation hub.”

Prior to the investment in Cherrywood, each country operation of Covidien in Europe was responding to customer questions, product orders, inquiries and returns separately and independently.  Now, the activity is centralized in the Cherrywood center, which is directly responsible for 16 countries and supports 58 countries indirectly. The employees in Cherrywood handle 6,500 contacts daily with over 50,000 products ordered each day.  Recruitment for positions at the site is nearing completion.

The official opening was also attended by Mr. Barry O’Leary, CEO of the IDA. Commenting at today’s opening, Mr. O’Leary said, “The establishment by Covidien of its European Services Centre in Dublin is strategically important to Ireland and the Company.  It is a welcome addition to the increasing number of leading life science companies who have recognised the benefits of locating European Services Centres here.  This operation fits neatly with IDA’s Horizon 2020 strategy, which places a strong focus on winning services-based investment and assisting companies to win new international mandates for Ireland.  Covidien’s Centre is an excellent operation and its establishment here is a vote of confidence in Ireland as a key location to carry out international services.”

About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2009 revenue of $10.7 billion, Covidien has 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit to learn more about our business.


Lisa Clemence                                               Suzanne Sullivan
Covidien                                                           Q4PR
Tel: 001-508-452-4375                                 Tel: 086-3797291
Email:         Email:

IDA Ireland
Antoinette Tyrrell, Press Officer, 01-6034256 / 0877572053


Our excellent experience here, coupled with the Government’s long-standing policies supporting business and innovation, clearly makes Ireland an ideal base for our Company - Richard J. Meelia, Chairman, President and CEO, Covidien